Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Osteosarcoma 1 Cognitive Dysfunction 1 Chemotherapy-Related Cognitive Impairment 1

Interventions

Methotrexate 5 Drug Therapy 5 apatinib 4 Neoadjuvant Therapy 4 Doxorubicin 3 camrelizumab 2 Ifosfamide 2 Cisplatin 2 trilaciclib 1 spartalizumab 1 palbociclib 1 isophosphamide mustard 1 irinotecan sucrosofate 1 glucarpidase 1 endostar protein 1 Zoledronic Acid 1 Vinorelbine 1 Triptorelin Pamoate 1 Trabectedin 1 Therapeutics 1 Thalidomide 1 TQ-B3525 1 Psychiatric Rehabilitation 1 Nivolumab 1 Neuropsychological Tests 1 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1 Microbiota 1 Metabolome 1 Magnetic Resonance Spectroscopy 1 Lithium Carbonate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Osteosarcoma × Ashwagandha × Clear all

NCT00689195 2011-06-23

OSCAT

Tata Memorial Hospital

Phase 1/2 Unknown

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡